6 Oct

Understanding BD’s Recent Stock Performance

WRITTEN BY Sarah Collins

BD’s stock performance

On October 5, 2017, Becton, Dickinson, and Company (BDX), or BD, closed the day at $197.25 per share. The stock has a 50-day moving average of $197.25, while its 200-day moving average is $192.35.

BD stock was trading at its 52-week high of $206.63 on July 25, 2017. On December 7, 2016, the stock registered its 52-week low of $161.29 per share.

Understanding BD’s Recent Stock Performance

BD released its latest quarterly earnings on August 3, 2017, and the company announced its 3Q17 results on the day. Its revenues came in lower than the Wall Street estimates, which triggered a slight decline in the stock’s price that day, but BD expects to register strong growth in fiscal 2017, with headwinds in 3Q17 not expected to impact future quarters.

BD stock has risen ~19.2% YTD (year-to-date). Over the past six months, the stock has gained 7.6%, but it has fallen 1.4% in the past month.

Peer and industry comparison

In the past 12 months, BD stock has registered a return of ~9.7%, while the S&P 500 Index has gained 17.7% during the same period, and the US medical device sector (IHI) has gained 17.2%.

On October 6, 2017, peers Stryker (SYK), Thermo Fisher Scientific (TMO), and Zimmer Biomet Holdings (ZBH) have gained ~27.4%, ~21.6%, and about -8.3%, respectively, over the past year.

In the next part, we’ll examine BD’s latest developments in diabetes.

Latest articles

Investors have been holding their breath for a Fed rate cut for a while now. But are they prepared in the event that that doesn't happen?

Innovative Industrial Properties (IIPR) continued to slump on July 22. The stock lost almost 6.8% of its value on the day.

22 Jul

Why AT&T Stock Is Down 2.2% Today

WRITTEN BY Ambrish Shah

AT&T stock (T) was trading at $32.14 with a 2.0% loss for the day. Earlier today, it posted a low of $32.08. Is the stock overvalued right now?

The Walt Disney Company’s (DIS) superhero film Avengers: Endgame has finally surpassed the record set by James Cameron’s Avatar.

22 Jul

Why Durect Corporation Is Soaring Today

WRITTEN BY Margaret Patrick

On July 22, Durect Corporation (DRRX) entered into a collaboration with HIV leader Gilead Sciences (GILD).

Pure Alpha, the flagship fund of Ray Dalio’s Bridgewater Associates, fell 4.9% in the first half, the Financial Times reported.